MedTrace Logo

Effect of Social Support Program on Grief of Pregnancy Loss in Sunpasitthiprasong Hospital

NCT06295939 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-03-29

No results posted yet for this study

Summary

Research Question:

Does participation in a social support program have an impact on the Perinatal Grief Scale of women who experience pregnancy loss through abortion? Research hypothesis

1. The grief scores from pregnancy loss among women who had to terminate their pregnancies in the group receiving social support program were lower than those in the group receiving standard nursing care.
2. The grief scores from pregnancy loss among women who had to terminate their pregnancies after receiving the social support program were lower than those before receiving the social support program.

Primary Objectives:

To study the grief and sorrow resulting from the loss of a fetus due to pregnancy termination in women who have undergone social support programs, in comparison to those who have received regular nursing care.

Secondary Objectives:

1. To investigate the grief and sorrow resulting from the loss of a fetus due to pregnancy termination after receiving social support programs compared to before receiving such programs.
2. To examine the grief and sorrow following pregnancy termination before returning home and one month after miscarriage.
3. To explore other outcomes of pregnancy termination, such as complete abortion, uterine curettage, and post-miscarriage complications.

Conditions

  • Pregnancy Loss
  • Grief
  • Social Support

Interventions

OTHER

social support program

Group 2, the experimental group, will receive routine nursing care from the assigned nurse and a social support program provided by the researcher, as follows: Phase 1 (Before Pregnancy Termination) Phase 2 (After Pregnancy Termination, Before Returning Home):

OTHER

Routine nursing care

The sample group will receive routine nursing care from the assigned nurse.

Sponsors & Collaborators

  • Sanpasitthiprasong Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-29
Primary Completion
2024-03-15
Completion
2024-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06295939 on ClinicalTrials.gov